Gordana Rasic, MS
Clinical Instructor, General Surgery
Biography
Dr. Gordana Rasic is evaluating the utility of circulating tumor DNA in peri-operative surveillance for persistent and/or recurrent oncologic disease, specifically in head and neck cancer. During her academic development time, she will also be working with the Surgical Outcomes Analysis Research (SOAR) Initiative to utilize national health databases to investigate factors contributing to healthcare disparities in hepatopancreatobiliary cancers. She currently serves as Senior Resident Research Director of the SOAR Initiative.
Education
- Eastern Virginia Medical School, DrMed
- Eastern Virginia Medical School, MS
- University of Illinois at Urbana–Champaign, BS
Publications
- Published on 10/1/2023
Chung SH, Romatoski KS, Rasic G, Beaulieu-Jones BR, Kenzik K, Merrill AL, Tseng JF, Cassidy MR, Sachs TE. ASO Visual Abstract: Impact of the COVID-19 Pandemic on Delays to Breast Cancer Surgery-Ripples or Waves? Ann Surg Oncol. 2023 Oct; 30(10):6104-6105. PMID: 37535273.
Read at: PubMed - Published on 9/1/2023
Romatoski KS, Chung SH, de Geus SWL, Papageorge MV, Woods AP, Rasic G, Ng SC, Tseng JF, Sachs TE. ASO Visual Abstract: Combined High-Volume Common Complex Cancer Operations Safeguard Long-Term Survival in a Low-Volume Individual Cancer Operation Setting. Ann Surg Oncol. 2023 Sep; 30(9):5363-5364. PMID: 37423928.
Read at: PubMed - Published on 8/1/2023
Chung SH, Romatoski KS, Rasic G, Beaulieu-Jones BR, Kenzik K, Merrill AL, Tseng JF, Cassidy MR, Sachs TE. Impact of the COVID-19 Pandemic on Delays to Breast Cancer Surgery: Ripples or Waves? Ann Surg Oncol. 2023 Oct; 30(10):6093-6103. PMID: 37526751.
Read at: PubMed - Published on 7/16/2023
Rasic G, Morris-Wiseman LF, Ortega G, Dent D, Nfonsam V, Arora TK. Effective Mentoring Across Differences-Best Practices and Effective Models to Address the Needs of Underrepresented Trainees in Surgical Residency Programs. J Surg Educ. 2023 Sep; 80(9):1242-1252. PMID: 37460368.
Read at: PubMed - Published on 7/1/2023
Rasic G, Beaulieu-Jones BR, Chung SH, Romatoski KS, Kenzik K, Ng SC, Tseng JF, Sachs TE. ASO Visual Abstract: The Impact of the COVID-19 Pandemic on Hepatocellular Carcinoma Time to Treatment Initiation: A National Cancer Database Study. Ann Surg Oncol. 2023 Jul; 30(7):4262-4263. PMID: 37103726.
Read at: PubMed - Published on 6/13/2023
Romatoski KS, Chung SH, de Geus SWL, Papageorge MV, Woods AP, Rasic G, Ng SC, Tseng JF, Sachs TE. Combined High-Volume Common Complex Cancer Operations Safeguard Long-Term Survival in a Low-Volume Individual Cancer Operation Setting. Ann Surg Oncol. 2023 Sep; 30(9):5352-5360. PMID: 37310536.
Read at: PubMed - Published on 5/25/2023
Romatoski KS, Chung SH, Kenzik K, Rasic G, Ng SC, Tseng JF, Sachs TE. Delay and Disparity in Observed vs Predicted Incidence Rate of Screenable Cancer During the COVID-19 Pandemic. J Am Coll Surg. 2023 May 25. PMID: 37227063.
Read at: PubMed - Published on 4/26/2023
Rasic G, Beaulieu-Jones BR, Chung SH, Romatoski KS, Kenzik K, Ng SC, Tseng JF, Sachs TE. The Impact of the COVID-19 Pandemic on Hepatocellular Carcinoma Time to Treatment Initiation: A National Cancer Database Study. Ann Surg Oncol. 2023 Jul; 30(7):4249-4259. PMID: 37099088.
Read at: PubMed - Published on 4/20/2023
Rasic G, Sachs TE. ASO Author Reflections: COVID-19 and Hepatocellular Carcinoma: Vulnerable Patient Populations Will Bear the Brunt of Delayed Treatment. Ann Surg Oncol. 2023 Jul; 30(7):4260-4261. PMID: 37079204.
Read at: PubMed - Published on 4/4/2023
Rasic G, Sachs TE. Invited Commentary. J Am Coll Surg. 2023 Jun 01; 236(6):1162-1163. PMID: 37184102.
Read at: PubMed
View 15 more publications: View full profile at BUMC